← Back to Search

Factors Influencing Migraine in Adolescents

N/A

Recruiting

Led By Hadas Nahman-Averbuch, PhD

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial looks at physical, hormonal, and psychological factors that may cause migraines in teenage girls.

Who is the study for?

This trial is for boys and girls aged 10-13, with or without a family history of migraines. It includes those who have not been diagnosed with migraines but show symptoms, as well as those who've had migraines for over six months. Participants should not be on new preventative treatments.Check my eligibility

What is being tested?

The study aims to understand factors predicting migraine onset and prognosis in adolescents by assessing pain responses, hormonal levels, brain activity through MRI scans, and how puberty status might influence these factors.See study design

What are the potential side effects?

Since the interventions include assessments rather than medications (like neural assessments and pressure stimuli), side effects are minimal but may include discomfort from testing procedures like MRI or temporary pain from pressure stimuli.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with a new diagnosis of migraine

Trial Design

2Treatment groups

Experimental Treatment

Group I: No Family History of MigraineExperimental Treatment10 Interventions

This group does not have a first or second degree relative diagnosed with migraine.

Group II: Family History of MigraineExperimental Treatment10 Interventions

This group has a first degree relative diagnosed with migraine.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MRI

2009

Completed Phase 2

~1370

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,937 Previous Clinical Trials

2,299,445 Total Patients Enrolled

1 Trials studying Migraine

100 Patients Enrolled for Migraine

Hadas Nahman-Averbuch, PhDPrincipal InvestigatorWashington University School of Medicine

3 Previous Clinical Trials

420 Total Patients Enrolled

1 Trials studying Migraine

100 Patients Enrolled for Migraine

Media Library

Family History of Migraine Clinical Trial Eligibility Overview. Trial Name: NCT05654012 — N/A

Migraine Research Study Groups: Family History of Migraine, No Family History of Migraine

Migraine Clinical Trial 2023: Family History of Migraine Highlights & Side Effects. Trial Name: NCT05654012 — N/A

Family History of Migraine 2023 Treatment Timeline for Medical Study. Trial Name: NCT05654012 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians admissible to this research study?

"The eligibility criteria for this trial calls for participants between the ages of 10 and 13. Additionally, there are 39 other research studies available to minors; whereas 127 medical trials accommodate elderly patients."

Answered by AI

Are individuals still able to apply for enrollment in this trial?

"Contrary to expectation, this medical study is not actively recruiting participants. Initially posted on the 1st of May 2023 and last edited April 20th 2023, this clinical trial has since been closed off from new patients. However, there are still 187 other trials currently looking for people like you."

Answered by AI